 |
|
|
  |
|
|
|
|
|
|
Designed for Acute Care™ Diagnostics
|
|
| |
 |
|
|
|
| For the POCT1-A Compliance Partnership Presentation, click here. |
| |
 |
|
Become POCT1-A Compliant with NCCLS Guidelines
Connectivity–Enhancing the Management of POCT (U.S. only)
Technology, regulations, reimbursement and marketing forces are driving tremendous changes in laboratory medicine.1 Valuable information from the laboratory can sometimes play a confirmatory or historical role in the care of patients because, all too often, the test results arrive at the bedside too late to be helpful in the ongoing care of the patient. In the modern era of evidence-based medicine, physicians are demanding that test results be available in real time and, if possible, at the point of care.1 This, coupled with advances in microfluidics and miniaturization technologies,2 has fueled the growth of Point-of-Care Testing (POCT). |
The ability of POCT to provide caregivers critical patient information in minutes has been shown to improve care.3 As a result, POCT has become the fastest growing segment of the In Vitro Diagnostics industry, with 45% of IVD testing projected to occur outside the lab by 2008.4 However, POCT has been associated with problems of which connectivity is the most significant.4 Studies have reported that:
| |
• |
82% of hospitals record POC tests manually4 |
| |
• |
63% of QC data is recorded manually4 |
| |
• |
67% of POC test results is not transferred to the hospital's LIS or HIS4 |
| |
• |
Less than 10% of POCT is billed1 |
| |
• |
As little as 10% of POCT is actually managed by the central laboratory computer1 |
As a result, connectivity and the ability to automatically integrate POC data with appropriate clinical information systems have become mandatory requirements.2,5-7
"...as little as 10 percent of point-of-care testing is actually managed by the central laboratory computer, hence, critically important results are not found on the patient's electronic medical record... those laboratories with no overall plan for data management of critical care testing will probably not survive this market driven paradigm. "
|
K.E. Blick, PhD.
The Journal of the International Federation of
Clinical Chemistry and Laboratory Medicine.1
|
|
|
References
|
|
|
 |
 |
 |
|
|
